These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 34601469)
1. Patterns of Use and Clinical Outcomes with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Heart Failure and Changes in Kidney Function: An Analysis of the Veterans' Health Administrative Database. Mathew RO; Lo KB; Tipparaju P; Phelps E; Sidhu MS; Bangalore S; Herzog C; Vaduganathan M; Tang WHW; Rangaswami J Cardiorenal Med; 2021; 11(5-6):226-236. PubMed ID: 34601469 [TBL] [Abstract][Full Text] [Related]
2. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999 [TBL] [Abstract][Full Text] [Related]
4. Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure. Yoshioka K; Matsue Y; Yamaguchi T; Kitai T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kuroda S; Matsumura A; Hirao K Am J Cardiovasc Drugs; 2019 Dec; 19(6):597-605. PubMed ID: 31218508 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin Receptor Neprilysin Inhibitor Use and Blood Pressure Lowering in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Kidney Function: An Analysis of the Veterans Administrative Health System. Gjyriqi G; York M; Abuazzam F; Herzog CA; Bangalore S; Lo KB; Sidhu MS; Vaduganathan M; Rangaswami J; Mathew RO J Card Fail; 2023 Mar; 29(3):258-268. PubMed ID: 36516938 [TBL] [Abstract][Full Text] [Related]
6. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure. Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928 [TBL] [Abstract][Full Text] [Related]
7. Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction. Kane JA; Kim JK; Haidry SA; Salciccioli L; Lazar J Cardiology; 2017; 137(2):121-125. PubMed ID: 28376504 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. Derington CG; Cohen JB; Mohanty AF; Greene TH; Cook J; Ying J; Wei G; Herrick JS; Stevens VW; Jones BE; Wang L; Zheutlin AR; South AM; Hanff TC; Smith SM; Cooper-DeHoff RM; King JB; Alexander GC; Berlowitz DR; Ahmad FS; Penrod MJ; Hess R; Conroy MB; Fang JC; Rubin MA; Beddhu S; Cheung AK; Xian W; Weintraub WS; Bress AP PLoS One; 2021; 16(4):e0248080. PubMed ID: 33891615 [TBL] [Abstract][Full Text] [Related]
9. Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis. Ishii T; Matsue Y; Matsunaga Y; Iekushi K; Homma Y; Morita Y Heart Vessels; 2024 Jan; 39(1):25-34. PubMed ID: 37695543 [TBL] [Abstract][Full Text] [Related]
10. Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure. Bertero E; Miceli R; Lorenzoni A; Balbi M; Ghigliotti G; Chiarella F; Brunelli C; Viazzi F; Pontremoli R; Canepa M; Ameri P Intern Emerg Med; 2019 Oct; 14(7):1083-1090. PubMed ID: 30835055 [TBL] [Abstract][Full Text] [Related]
11. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N; JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry. Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690 [TBL] [Abstract][Full Text] [Related]
13. Bioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure. McNaughton CD; Collins SP; Lindenfeld J; Morrison R; Daniels JS; Wang TJ Am J Ther; 2020; 27(4):e366-e370. PubMed ID: 31833870 [TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781 [TBL] [Abstract][Full Text] [Related]
15. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M; Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216 [TBL] [Abstract][Full Text] [Related]
16. Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure. Albert NM; Swindle JP; Buysman EK; Chang C J Am Heart Assoc; 2019 May; 8(9):e011089. PubMed ID: 31023122 [TBL] [Abstract][Full Text] [Related]
17. Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure. Carubelli V; Lombardi C; Specchia C; Peveri G; Oriecuia C; Tomasoni D; Di Pasquale M; Inciardi R; Garrafa E; Metra M ESC Heart Fail; 2021 Jun; 8(3):1944-1953. PubMed ID: 33660949 [TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease. Murphy DP; Wolfson J; Reule S; Johansen KL; Ishani A; Drawz PE J Am Soc Nephrol; 2023 Oct; 34(10):1721-1732. PubMed ID: 37545022 [TBL] [Abstract][Full Text] [Related]
19. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome. Ilges DT; Dermody ML; Blankenship C; Mansfield V; Van Tuyl JS J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):611-618. PubMed ID: 34138673 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with acute decompensated heart failure: a systematic review and meta-analysis. Pelayo J; Lo KB; Peterson E; DeFaria C; Nehvi A; Torres R; Maqsood MH; Farooq M; Mathew RO; Rangaswami J Expert Rev Cardiovasc Ther; 2021 Nov; 19(11):1037-1043. PubMed ID: 34751630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]